Drug-induced acute autoimmune hepatitis during combination therapy with atorvastatin and ezetimibe

被引:26
作者
van Heyningen, C [1 ]
机构
[1] Univ Hosp, Clin Labs, Liverpool L9 7AL, Merseyside, England
关键词
D O I
10.1258/0004563054890105
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
A case is presented of a patient who developed acute hepatitis during cholesterol-lowering treatment with atorvastatin and ezetimibe. Further investigations reveal a probable drug-induced autoimmune hepatitis, and ezetimibe is considered to be the most likely causal agent. This case is the first report of an autoimmune hepatitis associated with ezetimibe therapy.
引用
收藏
页码:402 / 404
页数:3
相关论文
共 10 条
  • [1] Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption
    Altmann, SW
    Davis, HR
    Zhu, LJ
    Yao, XR
    Hoos, LM
    Tetzloff, G
    Iyer, SPN
    Maguire, M
    Golovko, A
    Zeng, M
    Wang, LQ
    Murgolo, N
    Graziano, MP
    [J]. SCIENCE, 2004, 303 (5661) : 1201 - 1204
  • [2] Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia - A prospective, randomized, double-blind trial
    Ballantyne, CM
    Houri, J
    Notarbartolo, A
    Melani, L
    Lipka, LJ
    Suresh, R
    Sun, S
    LeBeaut, AP
    Sager, PT
    Veltri, EP
    [J]. CIRCULATION, 2003, 107 (19) : 2409 - 2415
  • [3] *BNF, 2004, EZETIMIBE SEP, P123
  • [4] Efficacy and safety of Ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia
    Gagné, C
    Bays, HÉ
    Weiss, SR
    Mata, P
    Quinto, K
    Melino, M
    Cho, M
    Musliner, TA
    Gumbiner, B
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (10) : 1084 - 1091
  • [5] Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: A randomized, double-blind, placebo-controlled trial
    Goldberg, AC
    Sapre, A
    Liu, J
    Capece, R
    Mitchel, YB
    [J]. MAYO CLINIC PROCEEDINGS, 2004, 79 (05) : 620 - 629
  • [6] Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis
    Graziadei, IW
    Obermoser, GE
    Sepp, NT
    Erhart, KH
    Vogel, W
    [J]. LUPUS, 2003, 12 (05) : 409 - 412
  • [7] Will the real cholesterol transporter please stand up
    Klett, EL
    Patel, SB
    [J]. SCIENCE, 2004, 303 (5661) : 1149 - 1150
  • [8] Ezetimibe - A review of its metabolism, pharmacokinetics and drug interactions
    Kosoglou, T
    Statkevich, P
    Johnson-Levonas, AO
    Paolini, JF
    Bergman, AJ
    Alton, KB
    [J]. CLINICAL PHARMACOKINETICS, 2005, 44 (05) : 467 - 494
  • [9] Target proteins in human autoimmunity: Cytochromes p450 and UDP-glucuronosyltransferases
    Obermayer-Straub, P
    Strassburg, CP
    Manns, MP
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 14 (05): : 429 - 439
  • [10] Valois Maria, 2003, Can J Clin Pharmacol, V10, P59